Cleared Traditional

LifeSignals Multi-Parameter Remote Monitoring Platform (K202868) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202868 · Lifesignals, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2021
Decision
296d
Days
Class 2
Risk

K202868 is an FDA 510(k) clearance for the LifeSignals Multi-Parameter Remote Monitoring Platform. Classified as Transmitters And Receivers, Physiological Signal, Radiofrequency (product code DRG), Class II - Special Controls.

Submitted by Lifesignals, Inc. (Fremont, US). The FDA issued a Cleared decision on July 21, 2021 after a review of 296 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2910 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifesignals, Inc. devices

Submission Details

510(k) Number K202868 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2020
Decision Date July 21, 2021
Days to Decision 296 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
171d slower than avg
Panel avg: 125d · This submission: 296d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRG Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2910
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

MethodSense, Inc.
Rita King

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DRG Transmitters And Receivers, Physiological Signal, Radiofrequency

All 54
Devices cleared under the same product code (DRG) and FDA review panel - the closest regulatory comparables to K202868.
Alio Medical Remote Monitoring System
K211365 · Graftworx, Inc. Dba Alio · Mar 2022
LifePath Remote Patient Monitoring Platform
K211822 · Elastic Care Incorporated · Feb 2022
ANNE One
K211305 · Sibel, Inc. · Sep 2021
LifeSignals ECG Remote Monitoring Patch Platform
K200690 · Lifesignals, Inc. · Jul 2020
Vitls Platform
K191620 · Vitls, Inc. · Jun 2020
Vista Solution Monitoring Kit, Vista Solution 2 10-day Evaluation Kit, VistaTablet 2 (Boxed)
K193343 · Vitalconnect, Inc. · Apr 2020